Ignota Labs Raises USD $6.9M Seed Funding to Turn Around Failed Drugs

Dr Layla Hosseini-Gerami named as one of Innovate UK’s trailblazing women innovators to watch in 2025

Ignota Labs secures Sanofi’s prestigious iDEA-Tech Award

Advancing predictive toxicology: overcoming hurdles and shaping the future

Maddyness: An interview with our CEO Sam Windsor

Ignota Labs In-Licenses First Proprietary Asset: Pioneering PDE9A Inhibitor Set to Transform Multi-Action Therapeutics

PharmaPhorum: Why drugs fail

AI for Pharma Growth: Rescuing failed drug projects